Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Lispro vs Insulin Aspart in T2D on CSII
NCT01474538Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2011
- Primary completion
- Feb 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of human insulin in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Dec 2011; status: completed.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01474538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01474538.